06 Jun 2022 Policy

An open letter to people with a weakened immune system

Leukaemia UK joins the NHS and other charity leaders by signing an open letter, to encourage people with a weakened immune system to continue to book in or visit a walk-in centre for their Covid-19 vaccines

The Joint Committee on Vaccination and Immunisation (JCVI) advises all individuals aged 12 years and over who are immunosuppressed should receive a Spring booster dose of the vaccine.

If you are immunosuppressed, either due to a health condition or medical treatment, you may not yet have the best protection you can possibly get from the vaccine.

You should usually be contacted by the NHS when you are due a Spring booster. Please do take up this offer. If you haven’t heard and you think you may be eligible then you can book a vaccination or find a convenient local walk-in site.

The JCVI recommends that people with a weakened immune system receive their Spring booster as close as possible to six months after their last dose for maximum protection. However, the booster can be given from three months where necessary, depending on individual circumstances.

The NHS has made some changes which means it has never been easier to get your booster if you are immunosuppressed. After booking, you can bring one of several documents to the appointment to confirm you are eligible. This should be one of the following:

  • A letter from your GP or specialist advising you get the jab
  • A hospital letter about your condition or medication
  • A prescription or medication box with your name and a date on it

If you don’t have any of this evidence to hand, don’t worry. It may still be possible to get vaccinated, just speak to a clinician when you arrive for your appointment.

Vaccination appointments can be booked quickly and conveniently by visiting www.nhs.uk/covid-vaccination, where you can also find out which vaccines you are eligible for.

There are three ways you can access your vaccination:

  • Make an appointment through the national booking service
  • Call 119 to book an appointment (calls are free and translators are available on request)
  • Find a walk-in site (not every walk-in site is able to offer vaccination for people who are immunosuppressed, so please use the NHS’ online finder to make sure you choose the right site for you)

Whether one of your vaccines is overdue or you haven’t had your first yet, please be assured that it isn’t too late.

Please let the NHS know if you have any difficulty accessing your vaccination so that the issue can be resolved and services can be improved.

There are a number of ways you can contact NHS England. Information about how to get in touch is available here on their website.

 

Fiona Hazell, CEO, Leukaemia UK

Professor Stephen Powis, National Medical Director, NHS England and NHS Improvement

Steve Russell, National Director for Vaccinations and Screening, NHS England and NHS Improvement

Dr Nikita Kanani MBE, Deputy Senior Responsible Officer, NHS Vaccine Deployment, and Medical Director for Primary Care, NHS England and NHS Improvement

Dr Jonathan Leach OBE, Medical Director for COVID-19 Vaccination, NHS England and NHS Improvement

Dr Bola Owolabi, Director, Healthcare Inequalities, NHS England and NHS Improvement

Henny Braund MBE, CEO, Anthony Nolan

Gemma Peters, CEO, Blood Cancer UK

Genevieve Edwards, CEO, Bowel Cancer UK

William Jones, CEO, Brainstrust

Alex Lochrane, CEO, The Brain Tumour Charity

Baroness Delyth Morgan, CEO, Breast Cancer Now

Mr Sharif Kaf Al-Ghazal, President, British Islamic Medical Association

Pamela Healy OBE, CEO, British Liver Trust

Matthew Patey OBE, CEO, British Skin Foundation

Dr Sanjeev Patel, President, British Society for Rheumatology

Professor Frank Chinegwundoh MBE, Chair, Cancer Black Care

Ian Walker, Executive Director of Policy, Information and Communications, Cancer Research UK

Jane Lyons, CEO, Cancer52

Rev Charles Kwaku-Odoi, Chief Officer, Caribbean and African Health Network

Eddie Chan, Co-Chair, Chinese Welfare Trust

Sarah Sleet, CEO, Crohn’s and Colitis UK

Louise Ansari, National Director, Healthwatch England

Umesh Sharma, Chair, Hindu Council UK

Samantha Dixon, CEO, Jo’s Cervical Cancer Trust

Nick Turkentine, CEO, Kidney Cancer UK

Paul Bristow, CEO, Kidney Care UK

Zack Pemberton-Whiteley, CEO, Leukaemia Care

Paul Howard, CEO, LUPUS UK

Dr Anthony Cunliffe, National Clinical Advisor Primary Care, Macmillan Cancer Support

Nick Moberly, CEO, MS Society

Sophie Castell, CEO, Myeloma UK

Deborah Gold, CEO, National AIDS Trust

Dr Charlotte Augst, CEO, National Voices

Ali Stunt, CEO, Pancreatic Cancer Action

Diana Jupp, CEO, Pancreatic Cancer UK

Laura Kerby, CEO, Prostate Cancer UK

Helen McAteer, CEO, The Psoriasis Association

Richard Davidson, CEO, Sarcoma UK

Sue Farrington, CEO, Scleroderma and Raynaud’s UK

Emma Willis, Co-CEO, Shine Cancer Support

Kirit Mistry, Chair, South Asian Health Action

Dr Binita Kane, Co-Founder, South Asian Heritage Month

Annwen Jones OBE, CEO, Target Ovarian Cancer

Kate Collins, CEO, Teenage Cancer Trust

Ian Green, CEO, Terrence Higgins Trust

Deborah Alsina MBE, CEO, Versus Arthritis

Related posts

Leukaemia UK bolsters research and advocacy team, in support of ambitious strategy to accelerate progress in the diagnosis, treatment, and care of leukaemia

30 January 2024

Leukaemia UK bolsters research and advocacy team, in support of ambitious strategy to accelerate progress in the diagnosis, treatment, and care of leukaemia

Leukaemia UK is pleased to announce Dr Simon Ridley as the new Director of Research and Advocacy and Dr Georgia Papacleovoulou as the organisation’s first ever Head of Policy and…

Widespread coverage of new leukaemia therapy shows promise in first trial patient

12 December 2022

Widespread coverage of new leukaemia therapy shows promise in first trial patient

As you may have seen in the news over the weekend, a clinical trial investigating a new leukaemia treatment has shown promising results. As part of the trial, funded by…

Dr Samanta Mariani recognised for her innovative research through Leukaemia UK John Goldman Fellowship and Olive Boles Innovation Award

11 August 2021

Dr Samanta Mariani recognised for her innovative research through Leukaemia UK John Goldman Fellowship and Olive Boles Innovation Award

We are delighted to announce the Leukaemia UK John Goldman Fellowship and Olive Boles Innovation Award has been awarded to Dr Samanta Mariani, in recognition of her innovative research that could contribute significantly to our understanding of leukaemia and other blood cancers.

Nurse who made throwaway comment before blood cancer diagnosis welcomes new research boost into ‘Natural Killer’ cells

29 February 2024

Nurse who made throwaway comment before blood cancer diagnosis welcomes new research boost into ‘Natural Killer’ cells

A former nurse, midwife, health visitor and NHS manager is welcoming new research into her particular blood cancer, after not recognising her mystery symptoms were leukaemia.  Kay Cutting, from Seaham…